Lexeo Therapeutics, a clinical-stage gene therapy company headquartered in New York City, seeks a Scientist II to design, execute, and analyze analytical development studies for AAV programs. You will lead assay development and contribute to GMP material release and regulatory submissions with cross-functional teams.
The role requires strong cell culture, analytical methods, and data interpretation skills, with collaboration across CMC, Quality, QC, and external partners.
#J-18808-LjbffrAnalytical Scientist II, AAV Gene Therapy in new york at Unknown Company
This position is listed as full time and onsite.